Deep Track Capital, LP - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Nurix Therapeutics, Inc. (NRIX)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Nurix Therapeutics, Inc. Common stock, par value $0.001 per share
Symbol
NRIX
Shares outstanding
70.8M shares
Disclosed Ownership
3M shares
Ownership
4.24%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 08:42 AM
Date of event
Dec 31, 2024
Next filing
Feb 14, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 4.24% 3M 0 3M /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 4.24% 3M 0 3M /s/ David Kroin David Kroin, Director
David Kroin 4.24% 3M 0 3M /s/ David Kroin David Kroin